Skip to content

Adient ADNT Equity income or loss

Equity income or loss at other companies

NovaGold Resources logo
NovaGold ResourcesNG
-$125.75K-40.1%
Adient logo
AdientADNT
$2M-27.3%
Jazz Pharmaceuticals logo
Jazz PharmaceuticalsJAZZ
$22.7M-49.7%
Silgan Holdings logo
Silgan HoldingsSLGN
$1.2M+3.1%
Tecnoglass logo
TecnoglassTGLS
$102K-92.4%
Ashland logo
AshlandASH
$0

Other financials

Income statement

See full
Revenue$3.9B+7.0%
Gross profit$257.0M-1.5%
Net income$27.0M+108%
EPS (diluted)$0.34+109%

Balance sheet

See full
Cash & equivalents$831.0M+10.2%
Total debt$2.6B+0.3%
Total equity$1.7B+3.7%
Total assets$9.0B+5.2%

Cash flow

See full
Operating cash flow$81.0M
CapEx$73.0M+62.2%
Free cash flow$8.0M+109%

Valuation

See full
Market cap$1.61B+46.7%
Enterprise value$3.41B+14.7%
P/E39.2×
P/S0.1×0.0×

Profitability

See full
Gross margin6.4%0.0pp
Net margin0.3%+0.1pp
FCF margin1.8%+0.2pp

Returns & leverage

See full
Return on equity2.4%+1.3pp
Debt / equity1.5×-0.1×
Current ratio1.1×0.0×

Where this comes from

Reported directly by Adient in its filing.

Tagged under the XBRL concept us-gaap:IncomeTaxReconciliationEquityInEarningsLossesOfUnconsolidatedSubsidiary.

The official record: Adient’s 10-K, filed November 18, 2025, on SEC EDGAR. View the filing →

Ask your AI about Adient's equity income or loss.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Adient's equity income or loss?
Adient (ADNT) reported equity income or loss of $2M in Q3 2025.
How has Adient's equity income or loss changed year-over-year?
Adient's equity income or loss decreased by 27.3% year-over-year, from $2.75M to $2M.
What is the long-term trend for Adient's equity income or loss?
Over 3 years (2022 to 2025), Adient's equity income or loss has grown at a 0.0% compound annual growth rate (CAGR), from $8M to $8M.
What does equity income or loss mean?
Reflects the company's share of net income or loss from investments in unconsolidated affiliates or joint ventures accounted for under the equity method. This metric highlights the profitability contribution from non-wholly owned business entities. It is a key indicator of the performance of strategic partnerships and joint ventures.